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Abstract 
Background 
There are various factors that can influence the survival of patients on Veno-arterial 
extracorporeal membrane oxygenation (VA ECMO). Vascular complications from femoral 
cannulation are common and are potentially serious. We analyzed the impact of vascular 
complications on survival of patients on VA ECMO. 
Methods 
Patients supported on VA ECMO via femoral cannulation from Oct 2010 to Nov 2014 were 
enrolled in this study. Data was gathered retrospectively by reviewing our institutional 
database. Patients were separated into two groups depending on the presence of major 
vascular complications, defined as patients that required surgical intervention. We 
evaluated predisposing factors for vascular complications and compared survival of 
patients in each group.  
Results 
There were 84 patients enrolled in the study. The rates of overall ECMO survival and 
survival to hospital discharge were 60% and 43% respectively. Major vascular 
complications requiring surgical intervention were seen in 17 (20%) patients. Ten patients 
(12%) had compartment syndrome requiring prophylactic fasciotomy and 10 patients 
(12%) had bleeding/hematoma requiring surgical exploration. The only significant 
predisposing factor for vascular complications was the absence of distal perfusion catheter 
(odds ratio 14.8, p=0.03). The rate of survival to discharge was 18% and 49% in patients 
with and without vascular complications (p=0.02). Vascular complications were an 
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independent factor of significantly worse survival in patients on VA ECMO by multivariate 
analysis (hazard ratio 2.17; P=0.02).  
Conclusions 
Vascular complications negatively affect survival in patients on VA ECMO support via 
femoral cannulation. The utilization of distal perfusion catheter can decrease the incidence 
of complications.  
 
Word count: 250 
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Introduction 
Extracorporeal membrane oxygenation (ECMO) is increasingly used for treatment of 
patients with critical cardiopulmonary failure (1-4). Recovery from ECMO largely depends 
on the underlining disease process since ECMO is only a supportive measure (4). Major 
complications of ECMO can include neurologic, cardiac, pulmonary, hemorrhagic and 
vascular issues, which lead to serious consequences (6, 7). The most common 
cannulation technique for adults requiring Venoarterial (VA) ECMO is percutaneous, via 
the femoral vessels because of their size and accessibility (4, 5). However, vascular 
complications related to femoral cannulation are one of the most common and serious 
complications of ECMO (6-12). Leg ischemia is particularly worrisome and a distal 
perfusion catheter is often placed to prevent ischemia (13, 14). The relationship between 
major vascular complications and outcomes of patients on ECMO is still unclear (11, 12). 
We have evaluated the impact of vascular complications on survival in patients on VA 
ECMO via femoral percutaneous cannulation. 
 
Patients and Methods 
Patients 
Adult patients (age > 16 years old) supported on VA ECMO via femoral percutaneous 
cannulation from October 2010 to November 2014 were enrolled in this study. Data was 
collected by retrospectively reviewing medical charts and our institutional database, which 
was approved by the institutional review board. All patients were included regardless of 
indication (cardiogenic shock, respiratory failure, or both). Major vascular complications 
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related to cannulation were defined as those that required surgical intervention. Surgical 
indications include surgical bleeding that required more than 2 units of blood and/or 
symptomatic limb ischemia (change in appearance, decrease in oximetry and/or loss of 
pulse). Complications in which surgical intervention was withheld due to patient death or 
withdrawal of care were counted as major complications. Patients were separated into two 
groups depending on the presence of major vascular complications. Minor vascular 
complications managed conservatively were evaluated separately.  
Procedure 
All cannulation was performed percutaneously at the bedside without fluoroscopy by a 
modified Seldinger technique unless there was technical difficulty. The size of the cannula 
was chosen based on desired flow for the patient. A distal perfusion catheter (DPC) was 
placed routinely at the same time unless there was technical difficulty or the patient was 
too unstable. A single dose of heparin (5000-7500 IU) was administered upon cannulation. 
Continuous heparin was started no more than 24 hours after cannulation aiming for a PTT 
goal of 45 to 55 seconds (5).  
When the patient had clinically improved, a weaning trial was performed at the bedside 
using the protocol previously described (15). If the patient tolerated the trial satisfactorily, 
the patient was taken to the operating room for decannulation. All decannulation was 
performed after exposing femoral vessels. The femoral artery was repaired primarily with 
interrupted sutures of 5-0 Prolene or using bovine pericardial patch. A purse-string suture 
of 4-0 or 5-0 Prolene was used to repair the femoral vein. A vacuum-assisted closure 
(VAC® KCI, San Antonio, Texas) dressing was routinely placed after closure of the fascia.  
Study design 
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Patients were divided into 2 groups – group I with major vascular complications and group 
II without major vascular complications. Demographics between groups were compared 
using univariate and multivariate analysis including all variables to evaluate predisposing 
factors. The groups were also compared for outcomes. Mortality was the primary outcome 
and the secondary outcome was the occurrence of any major complications during ECMO 
support. Kaplan-Meier survival curves were drawn for each group and survival distributions 
were compared. Multivariate analysis was also performed to validate the result. 
Predisposing factors for mortality were evaluated by comparing 30-day survivors to non-
survivors. After identifying significant predisposing factors for mortality, multivariate 
analysis was performed to determine the significance of vascular complications upon 
survival. 
Statistical analysis 
Continuous variables were expressed as mean ± standard deviation and compared with 
Student’s t-test. Categorical variables were evaluated by chi-square test or Fisher’s exact 
test as univariate analysis. Logistic regression analysis was utilized for multivariate 
analysis and odds ratios were calculated. Survival distributions were compared with log 
rank test as univariate analysis and Cox proportional hazards model as multivariate 
analysis. Hazard ratio was also calculated. P values of less than 0.05 were deemed 
statistically significant. Statistical analysis was performed using the R statistical software 
package version 3.1.2 (R foundation, Vienna, Austria). 
 
Results 
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There were 84 patients who met enrollment criteria. The ECMO survival rate (patients 
successfully weaned from ECMO) and the rate of survival to hospital discharge were 60% 
and 43% respectively. Median length of survival was 32 days (95% confidence interval (CI) 
17-200). Seventeen patients (20%) had at least one episode of major vascular 
complication, including 10 patients (12%) with leg ischemia who progressed to 
compartment syndrome requiring prophylactic fasciotomy and 10 patients (12%) with 
significant bleeding and/or hematoma at the cannulation site to require surgical exploration. 
Three patients had both ischemic and hemorrhagic complications. None of patients 
required limb amputation. 
Predisposing factors for vascular complications 
Table 1 shows demographics of patients with and without vascular complications. Age and 
absence of distal perfusion catheter were significantly different between the two groups by 
univariate analysis. However, by multivariate analysis, only absence of distal perfusion 
catheter was a significant predisposing factor (odds ratio 18.7; p=0.03) (Table 2). The 
other factors including history or risk factors of peripheral vascular disease and severity of 
baseline condition were not significantly associated with vascular complications.  
Outcome 
Table 3 shows outcome of patients with and without vascular complication. Patients with 
vascular complication required significantly more procedures (p=0.01) but there was no 
difference in the amount of transfusion required. Duration of ECMO support and hospital 
stay were not significantly different. Patients with a major vascular complication were more 
likely to experience disseminated intravascular coagulation (DIC). 
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Impact of Vascular Complications on Survival 
Univariate analysis: The rates of survival to discharge were 18% and 49% in patients with 
and without a major vascular complication (p=0.02). Figure 1 shows Kaplan-Meier curves 
of patients with and without vascular complication. Survival length of patients without 
vascular complication was significantly better than that of patients with vascular 
complication by univariate analysis (p=0.002). Table 4 shows the hazard ratio for each 
vascular complication. Major ischemic complication (compartment syndrome) had highest 
hazard ratio (3.03; p=0.003) followed by major bleeding/hematoma that required surgical 
intervention (1.93; p=0.09). The hazard ratio of bleeding/hematoma was lower than that of 
ischemia. The hazard ratio of major complications (i.e. those that required surgical 
intervention) was higher than that of minor complications (i.e. those treated conservatively). 
The influence of a distal perfusion catheter on survival was also evaluated because its 
absence predisposed patients to a vascular complication. Length of survival tended to be 
worse in patients without a DPC initially although it was not significant (hazard ratio 0.79; 
p=0.48). 
Multivariate analysis: For multivariate analysis, comparing 30-day survivors to non-
survivors identified predisposing factors for mortality. Table 5 shows predisposing factors, 
which influenced 30-day mortality significantly by univariate analysis. It also shows the 
result of Cox proportional hazards model for each factor. A major vascular complication 
was an independent factor for significantly worse survival by multivariate analysis (hazard 
ratio 2.17; p=0.02). Neurologic complications also predicted mortality (hazard ratio 7.80; 
P<0.0001). 
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Comment 
There are a number of factors that can influence survival of patients on ECMO (1-4). The 
preoperative factor that influences outcome the most is probably the underlining condition 
of the patient (4). Therefore, ECMO is indicated only if recovery is expected or as a bridge 
to further treatment . Once ECMO is initiated, it is often the complications of ECMO that 
determine the fate of the patient (6, 7). Neurologic complications are probably the most 
devastating because they are often irreversible and lead to the withdrawal of care from the 
patient (7).  
Vascular complications are relatively frequent and serious in nature (6, 11). The majority of 
VA ECMO is performed by percutaneous femoral cannulation. Lower extremity ischemia 
and bleeding from the cannulation site can pose serious problems. In our study, vascular 
complications were an independent factor of significantly worse survival of patients on VA 
ECMO via femoral cannulation. Whereas there is usually a direct correlation between a 
major neurologic complication and mortality, the link between vascular complications and 
mortality is less clear (7). In our study, only 2 out of 17 patients with a major vascular 
complication seemed to have a direct link between the complication and mortality. Patients 
with vascular complications had a higher number of procedures per patient and an 
increased frequency of DIC. The ischemic process, multiple procedures and transfusions 
exacerbate the systemic inflammatory response related to ECMO, leading to increased 
risk for mortality (16).  
Our data demonstrated that ischemic complications had a greater impact upon mortality 
than bleeding/hematoma, suggesting that the pathophysiology of the injury is more 
significant with ischemia. Ischemia can be caused by vascular occlusion from the cannula, 
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thromboembolization or dissection of the artery. Bleeding and hematoma are usually 
caused by vascular injury (laceration, perforation, dissection). The inflammatory response 
and hemodynamic effects of ischemia are different from the response from blood loss and 
transfusions, potentially accounting for the differential effect on outcome.  
Considering the impact of vascular complications on mortality, prevention is very important. 
Although the impact upon mortality of bleeding/hematoma is smaller than that of ischemia, 
prevention of this complication may be more difficult because it relies on cannulation 
technique and anatomy of the patient. While direct cut down may prevent some technical 
complications, we adopted a preference for percutaneous cannulation since we seemed to 
have a lower incidence of infection and bleeding after percutaneous cannulation compared 
to open cannulation. However, given the multiple variables involved and lack of a formal 
study protocol, we do not have adequate data to support this claim. Appropriate imaging 
with fluoroscopy helps for safer cannulation. However, fluoroscopic equipment is not 
readily available for emergency use in all areas of the hospital, necessitating a high 
reliance on cannulation without imaging. Concerning other predisposing factors for 
vascular complication, older age and elevated BMI tended to decrease the risk of vascular 
complication. The etiology of this apparent effect is unknown.  
In our study, the only significant predisposing factor for vascular complication by 
multivariate analysis was absence of a distal perfusion catheter (DPC). The efficacy of the 
DPC has been reported in a few retrospective studies (1, 8, 13). There is a data that DPC 
can actually increase lower limb perfusion (17). In our institution, DPCs are placed 
routinely unless there is technical difficulty or patient instability. Placement of the DPC was 
associated with a lower risk of vascular complications in this study. Comparing survival of 
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patients with and without DPC, there was a trend towards an increase in short-term 
survival in patients with DPC, although it was not statistically significant. The relatively 
small size of the study population may have limited our ability to discern a difference if it 
does exist. Utilizing an alternate cannulation site is another way to prevent ischemic 
complications (18-21). The risk of ischemic complication of axillary artery cannulation is 
reported to be lower than that of femoral cannulation (18). However, the risk of bleeding 
and limb hyper-perfusion is significantly higher in axillary cannulation (18). In addition, 
placement of ECMO cannulas via the femoral vessels requires less specialized training 
and equipment, and thus may have the advantage of quicker institution of ECMO support 
in many situations. Placement of DPC is the easiest and the most effective measure to 
prevent lower limb ischemia. 
Monitoring of lower extremity perfusion is also very important in the prevention and early 
recognition of ischemic complications. In addition to periodical physical examinations and 
laboratory tests, we use near-infrared spectroscopy to monitor lower extremity perfusion 
continuously. If spectroscopy suggests ischemia is present, patency of the DPC is 
checked to make sure there is no clot or kink, followed by angiography if necessary to 
check position and look for possible thrombosis or embolization. Prophylactic fasciotomy is 
performed if compartment syndrome is suspected. Utilizing those preventive measures, we 
have managed to avert any ischemia severe enough to require limb amputation. 
There is limited data regarding the influence of vascular complications of ECMO on 
outcomes (11, 12). Bisdas and colleagues concluded that there was no significant 
difference in mortality between patients with and without vascular complications (11). A 
major difference from our study was that they compared mortality rates at certain periods 
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rather than survival distributions of patients. Comparing survival distributions might have 
yielded more accurate data. Another difference is they included veno-venous (VV) ECMO 
via femoral cannulation in their analysis. VV ECMO is often used in a different patient 
population with a different expected survival than that seen in VA ECMO, largely due to 
differences in the underlying disease processes. In addition, the mechanism of vascular 
complication would be completely different from that seen in VA ECMO. Including such 
disparate groups of patients may obscure a difference in outcome if it did exist. We have 
focused our study on the complications of arterial cannulation to minimize the variables 
between the groups of patients studied. Finally, Bisdas and colleagues included minor and 
severe vascular complications together, and they did not seem to include bleeding from 
the cannulation site as a complication even though it is frequent and a potentially serious 
complication. 
One limitation of the current study is its retrospective design using a database and medical 
charts. Therefore, analysis of predisposing factors for vascular complication might be 
biased, although we tried to minimize this using multivariate analysis. We had a very small 
number of patients with PAD in our study. Considering that the majority of patients with 
PAD are asymptomatic, we might have underreported the incidence of PAD in our patient 
population (22). We also looked at the presence or absence of a DPC, but did not identify 
why a DPC was not placed. It is difficult to tell whether absence of a DPC caused vascular 
complication or if the factor that prevented placement (like PAD) caused the vascular 
complication.  We also have a relatively small sample cohort, especially in vascular 
complication group, which could make the data less accurate. Given the small cohort sizes, 
the lack of statistical significance does not necessarily imply the lack of clinical significance 
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so there may be other factors that lead to vascular complication or affect survival that were 
not detected in this study. 
In conclusion, vascular complications worsen survival of adult patients on VA ECMO via 
femoral cannulation. Ischemic complications influence outcome more than bleeding 
complications. Placement of distal perfusion catheter can decrease the risk of vascular 
complication. 
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Table1: Demographics of patients with and without vascular complications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With vascular 
complication 
Without vascular 
complication P value 
Number 17 67  
Male 11 (65%) 48 (72%) 0.58 
Age 40.9±13.5 50.3±14.3 0.02† 
BSA 1.93±0.26 2.01±0.31 0.32 
BMI 29.0±9.1 29.2±6.3 0.94 
Smoking 3 (18%) 25 (37%) 0.16 
CAD 6 (35%) 28 (42%) 0.78 
PAD 1 (6%) 2 (3%) 0.50 
Diabetes 5 (29%) 19 (28%) 0.99 
COPD 2 (12%) 8 (12%) 0.99 
Liver dysfunction 4 (24%) 8 (12%) 0.25 
Steroid and/or 
Immunosuppression 4 (24%) 7 (10%) 0.22 
Post cardiotomy 4 (24%) 9 (13%) 0.29 
Cardiac failure 15 (88%) 55 (82%) 0.73 
Respiratory failure 15 (88%) 60 (90%) 0.99 
Sepsis 0 4 (6%) 0.58 
Salvage or emergent 14 (82%) 53 (79%) 0.28 
CKD class 4 or 5 5 (29%) 13 (19%) 0.32 
APACHE II score 30.3±6.0 29.1±8.1 0.56 
Arterial cannula (Fr) 19.8±2.3 19.7±1.7 0.72 
Primary indication  
       Cardiac 
       Respiratory 
 
16 (94%) 
1 (6%) 
 
56 (74%) 
11 (16%) 
0.44 
No distal perfusion 7 (41%) 10 (15%) 0.02† 
18 
 
 
†: Statistically significant (p<0.05) 
Continuous data are expressed as mean ± standard deviation.  
APACHE: acute physiologic and chronic health evaluation; BMI: body mass index; BSA: 
body surface area; CAD: coronary artery disease; CKD: chronic kidney disease; COPD: 
chronic obstructive lung disease; PAD: peripheral artery disease 
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Table 2: Predisposing factors for vascular complications (multivariate logistic regression)  
 
 
 
 
 
 
 
 
Only factors with p values less than 0.5 are shown. 
†: Statistically significant (p<0.05) 
APACHE: acute physiologic and chronic health evaluation; BMI: body mass index; CAD; 
coronary artery disease; CKD: chronic kidney disease 
 
 
  
 Odds ratio 95% Confidence interval P value 
Age ≥ 60 0.16 0.002 to 9.28 0.38 
Obesity (BMI ≥ 30) 0.17 0.01 to 3.87 0.26 
CAD 0.11 0.01 to 1.76 0.12 
Post cardiotomy 10.2 0.34 to 404 0.17 
CKD class 4 or 5 4.02 0.29 to 56.4 0.30 
APACHE II score ≥ 30 3.82 0.50 to 29.2 0.20 
Arterial cannula ≥ 20 Fr 1.46 0.16 to 13.6 0.20 
No distal perfusion 18.7 1.34 to 261 0.03† 
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 Table 3: Outcomes 
 
With vascular 
complication 
Without vascular 
complication P value 
Medical resources    
   Number of procedures 2.8 ± 2.1 1.3 ± 1.5 0.002† 
   PRBC (units) 20.0 ± 20.7 14.4 ± 17.0 0.25 
   Days on ECMO if survived 14.6 ± 6.7 10.6 ± 7.5 0.16 
   Length of stay if survived 33.0 ± 2.4 53.3 ± 63.0 0.10 
Complications    
   Cardiac complications 0 11 (16%) 0.11 
   Respiratory complications 5 (29%) 15 (22%) 0.54 
   Neurologic complications 7 (41%) 17 (25%) 0.23 
   Acute kidney injury 6 (35%) 15 (22%) 0.35 
   Disseminated intravascular 
   coagulation 5 (29%) 2 (3%) 0.003† 
Survival    
   ECMO survival 8 (47%) 49 (73%) 0.08 
   Survived to discharge 3 (18%) 32 (48%) 0.02† 
   Median survival (days) 11 (4-30) 48 (21-NA) 0.002† 
21 
 
 
 
†: statistically significant (p<0.05) 
PRBC: packed red blood cells  
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Table 4: Impact of each vascular complication (Cox proportional hazards model) 
 Severity Hazard ratio 95% confidence interval P value 
All vascular 
complication  
Major 2.52 1.37 to 4.63 0.003† 
Minor 1.22 0.54 to 2.77 0.63 
Cannulation site 
bleeding/hematoma 
Major 1.93 0.90 to 4.13 0.09 
Minor 1.12 0.44 to 2.86 0.81 
Lower extremity 
ischemia 
Major 3.03 1.50 to 6.10 0.002† 
Minor 1.37 0.42 to 4.46 0.60 
 
†: Statistically significant (p<0.05) 
Major complications are those that required surgical intervention. Minor complications are 
those managed conservatively. 
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Table 5: Impact of each complication on survival of patients on VA ECMO by multivariate 
analysis (Cox proportional hazards model) 
 
 Hazard ratio 95% confidence interval P value 
Vascular complication 2.17 1.12 to 4.20 0.02† 
Neurologic complication 7.80 3.44 to 17.72 <0.001† 
Acute kidney injury 0.99 0.51 to 1.88 0.96 
Disseminated 
intravascular coagulation 1.57 0.57 to 4.30 0.38 
Clinically significant 
thrombosis/embolization 0.84 0.36 to 2.00 0.70 
 
†: Statistically significant (p<0.05) 
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Figure Legends 
Figure 1: Kaplan-Meier survival curve of patients with and without vascular complication 
Dashed lines show 95% confidence intervals. 

